2022
DOI: 10.3390/antibiotics11040508
|View full text |Cite
|
Sign up to set email alerts
|

High Carriage of Extended-Spectrum, Beta Lactamase-Producing, and Colistin-Resistant Enterobacteriaceae in Tibetan Outpatients with Diarrhea

Abstract: Antibiotic-resistant bacteria (ARB) and antibiotic-resistance genes (ARGs) have been detected in human-impacted habitats, especially in densely populated cities. The Qinghai–Tibet Plateau is located far from the heavily populated regions of China, and Tibetan residents have distinct dietary habits and gut microbes. Antibiotic-resistance monitoring in the Tibetan population is rare. Here, we collected stool samples from Tibetan outpatients with diarrhea. From 59 samples, 48 antibiotic-resistant Enterobacteriace… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…Klebsiella pneumoniae (30.6%) was the predominant ESBL producer among GNB isolates from severely ill COVID-19 patients. Even though data on ESBL-producing bacteria in COVID-19 patients is limited, in the general population, E. coli and K. pneumoniae [ 31 34 ] seems to be the most common ESBL producers. Our finding may infer similarity in ESBL-producing bacteria profiles among COVID-19 and non-COVID patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Klebsiella pneumoniae (30.6%) was the predominant ESBL producer among GNB isolates from severely ill COVID-19 patients. Even though data on ESBL-producing bacteria in COVID-19 patients is limited, in the general population, E. coli and K. pneumoniae [ 31 34 ] seems to be the most common ESBL producers. Our finding may infer similarity in ESBL-producing bacteria profiles among COVID-19 and non-COVID patients.…”
Section: Discussionmentioning
confidence: 99%
“…Emeraud et al documented a nosocomial outbreak of ESBL producing K. pneumoniae carrying CTX-M-15 in a French intensive care unit dedicated to COVID-19 during the first wave of the pandemic [ 37 ], however, information on ESBL gene carriage among ESBL producing GNB that cause infections in COVID-19 patients is limited. Before the year 2000, SHV- and TEM–type enzymes were the most predominant ESBLs worldwide [ 38 ] but have since been outnumbered by CTX-M ESBLs in non-COVID19 patients [ 39 , 40 , 11 , 34 ]. Therefore, our findings suggest a similar ESBL gene carriage among bacterial isolates from COVID-19 patients and the general population.…”
Section: Discussionmentioning
confidence: 99%
“…French intensive care unit dedicated to COVID-19 during the rst wave of the pandemic [36], however, information on ESBL gene carriage among ESBL producing GNB that cause infections in COVID-19 patients is limited. Before the year 2000, SHV-and TEM-type enzymes were the most predominant ESBLs worldwide[37] but have since been outnumbered by CTX-M ESBLs in non-COVID19 patients [38][39] [10][33]. Therefore, our ndings suggest a similar ESBL gene carriage among bacterial isolates from COVID-19 patients and the general population.…”
mentioning
confidence: 70%
“…Klebsiella pneumoniae (30.6%) was the predominant ESBL producer among GNB isolates from severely ill COVID-19 patients. Even though data on ESBL-producing bacteria in COVID-19 patients is limited, in the general population, E. coli and K. pneumoniae[30] [31] [32][33] seems to be the most common ESBL producers.…”
mentioning
confidence: 99%
“…8 Treating Multi drug resistant bacteria, colistin was used as a last line of antibiotic for gram negative bacteria. 9 After the detection of mcr genes on plasmid of gram-negative bacteria disclosed that colistin resistance can be horizontally transferred. 10,11 ESBL, MBL, AmpC producing gram negative bacteria with mcr genes harboring by Enterobacteriaceae have been discovered all over the world, putting people at risk of having no effective antibacterial treatments.…”
Section: Introductionmentioning
confidence: 99%